+ All Categories
Home > Documents > OVERVIEW OF STATE APPROACHES TO OVERSIGHT AND MONITORING OF PSYCHOTROPIC MEDICATIONS Joyce Pfennig,...

OVERVIEW OF STATE APPROACHES TO OVERSIGHT AND MONITORING OF PSYCHOTROPIC MEDICATIONS Joyce Pfennig,...

Date post: 05-Jan-2016
Category:
Upload: damon-melton
View: 213 times
Download: 0 times
Share this document with a friend
Popular Tags:
22
OVERVIEW OF STATE APPROACHES TO OVERSIGHT AND MONITORING OF PSYCHOTROPIC MEDICATIONS Joyce Pfennig, Ph.D. Kate Stepleton, MSW
Transcript
Page 1: OVERVIEW OF STATE APPROACHES TO OVERSIGHT AND MONITORING OF PSYCHOTROPIC MEDICATIONS Joyce Pfennig, Ph.D. Kate Stepleton, MSW.

OVERVIEW OF STATE APPROACHES TO OVERSIGHT AND MONITORING OF PSYCHOTROPIC MEDICATIONSJoyce Pfennig, Ph.D.Kate Stepleton, MSW

Page 2: OVERVIEW OF STATE APPROACHES TO OVERSIGHT AND MONITORING OF PSYCHOTROPIC MEDICATIONS Joyce Pfennig, Ph.D. Kate Stepleton, MSW.

Annual Progress and Services Reports (APSRs)

Page 3: OVERVIEW OF STATE APPROACHES TO OVERSIGHT AND MONITORING OF PSYCHOTROPIC MEDICATIONS Joyce Pfennig, Ph.D. Kate Stepleton, MSW.

Child and Family Services Improvement and Innovation Act of 2011

Page 4: OVERVIEW OF STATE APPROACHES TO OVERSIGHT AND MONITORING OF PSYCHOTROPIC MEDICATIONS Joyce Pfennig, Ph.D. Kate Stepleton, MSW.

Required Components of Psychotropic Oversight and Monitoring Plan

Program Instruction ACYF-CB-PI-12-05: http://www.acf.hhs.gov/programs/cb/laws_policies/policy/pi/2012/pi1205.pdf

Page 5: OVERVIEW OF STATE APPROACHES TO OVERSIGHT AND MONITORING OF PSYCHOTROPIC MEDICATIONS Joyce Pfennig, Ph.D. Kate Stepleton, MSW.

Required Components of Psychotropic Oversight and Monitoring Plan

Page 6: OVERVIEW OF STATE APPROACHES TO OVERSIGHT AND MONITORING OF PSYCHOTROPIC MEDICATIONS Joyce Pfennig, Ph.D. Kate Stepleton, MSW.

Required Components of Psychotropic Oversight and Monitoring Plan

Page 7: OVERVIEW OF STATE APPROACHES TO OVERSIGHT AND MONITORING OF PSYCHOTROPIC MEDICATIONS Joyce Pfennig, Ph.D. Kate Stepleton, MSW.

Required Components of Psychotropic Oversight and Monitoring Plan

Page 8: OVERVIEW OF STATE APPROACHES TO OVERSIGHT AND MONITORING OF PSYCHOTROPIC MEDICATIONS Joyce Pfennig, Ph.D. Kate Stepleton, MSW.

Required Components of Psychotropic Oversight and Monitoring Plan

Page 9: OVERVIEW OF STATE APPROACHES TO OVERSIGHT AND MONITORING OF PSYCHOTROPIC MEDICATIONS Joyce Pfennig, Ph.D. Kate Stepleton, MSW.

Synthesis of State Plans

Page 10: OVERVIEW OF STATE APPROACHES TO OVERSIGHT AND MONITORING OF PSYCHOTROPIC MEDICATIONS Joyce Pfennig, Ph.D. Kate Stepleton, MSW.

Caveats

Page 11: OVERVIEW OF STATE APPROACHES TO OVERSIGHT AND MONITORING OF PSYCHOTROPIC MEDICATIONS Joyce Pfennig, Ph.D. Kate Stepleton, MSW.

Screening, Assessment and Treatment

Page 12: OVERVIEW OF STATE APPROACHES TO OVERSIGHT AND MONITORING OF PSYCHOTROPIC MEDICATIONS Joyce Pfennig, Ph.D. Kate Stepleton, MSW.

Informed and Shared Decision-Making

Page 13: OVERVIEW OF STATE APPROACHES TO OVERSIGHT AND MONITORING OF PSYCHOTROPIC MEDICATIONS Joyce Pfennig, Ph.D. Kate Stepleton, MSW.

Medication Monitoring

Page 14: OVERVIEW OF STATE APPROACHES TO OVERSIGHT AND MONITORING OF PSYCHOTROPIC MEDICATIONS Joyce Pfennig, Ph.D. Kate Stepleton, MSW.

Mental Health Expertise and Consultation

Page 15: OVERVIEW OF STATE APPROACHES TO OVERSIGHT AND MONITORING OF PSYCHOTROPIC MEDICATIONS Joyce Pfennig, Ph.D. Kate Stepleton, MSW.

Mechanisms for Sharing Accurate and Up-To-Date Information

Page 16: OVERVIEW OF STATE APPROACHES TO OVERSIGHT AND MONITORING OF PSYCHOTROPIC MEDICATIONS Joyce Pfennig, Ph.D. Kate Stepleton, MSW.

Common Approaches and Innovative Ideas

Page 17: OVERVIEW OF STATE APPROACHES TO OVERSIGHT AND MONITORING OF PSYCHOTROPIC MEDICATIONS Joyce Pfennig, Ph.D. Kate Stepleton, MSW.

General Observations

There is significant variation in approaches across States

States describe a mix of current and proposed approaches

States rarely addressed both client- AND agency-level protocols

Few States described procedures related to ALL FIVE components

Widespread adoption of AACAP guidelines

Page 18: OVERVIEW OF STATE APPROACHES TO OVERSIGHT AND MONITORING OF PSYCHOTROPIC MEDICATIONS Joyce Pfennig, Ph.D. Kate Stepleton, MSW.

Screening, Assessment and Treatment Many States are using EPSDT as screening

and assessment mechanism Several States ensure that a trauma-

informed assessment is completed At entry Within 30 days of placement Within 45 days of placement

Integration with other screening and assessment activities

Innovative: Use of telemedicine – required initial screening completed over the phone using validated screening tools

Page 19: OVERVIEW OF STATE APPROACHES TO OVERSIGHT AND MONITORING OF PSYCHOTROPIC MEDICATIONS Joyce Pfennig, Ph.D. Kate Stepleton, MSW.

Informed Consent and Shared Decision-Making Approaches emphasized assent as well

as consent – youth involvement in decision-making

Several States give birth parent decision-making authority until parental rights have been terminated

Some States describe protocols for contesting decisions

Page 20: OVERVIEW OF STATE APPROACHES TO OVERSIGHT AND MONITORING OF PSYCHOTROPIC MEDICATIONS Joyce Pfennig, Ph.D. Kate Stepleton, MSW.

Medication Monitoring

Mix of retrospective and prospective approaches Many States are using red flags to trigger reviews

Prescription of antipsychotic to child under 6 Prescription of 2 or more antipsychotics for more

than 60 days Many States use Drug Utilization Review (DUR)

Programs to monitor psychotropic medication use Feedback reports to providers to address

prescribing that does not align with best practices

Direct links between SACWIS and Medicaid information system facilitate monitoring

Page 21: OVERVIEW OF STATE APPROACHES TO OVERSIGHT AND MONITORING OF PSYCHOTROPIC MEDICATIONS Joyce Pfennig, Ph.D. Kate Stepleton, MSW.

Mental Health Expertise and Consultation Innovative: Trauma consultation in complex

cases Trauma specialist as part of review team for

consultation in cases where multiple medication changes have not resulted in improvements in symptoms

Trauma-informed technical assistance hotlines for providers

Innovative: Creative solutions to deal with shortage areas (provider consultation lines)

Page 22: OVERVIEW OF STATE APPROACHES TO OVERSIGHT AND MONITORING OF PSYCHOTROPIC MEDICATIONS Joyce Pfennig, Ph.D. Kate Stepleton, MSW.

Mechanisms for Sharing Accurate and Up-To-Date Information Several States described use of medical

passports or use of electronic health records that incorporate behavioral health

Use of interagency linkages – such as MOUs for the development of shared records

Tools to ensure informed consent Guide and tools for youth Resources for foster parents Trainings for caseworkers


Recommended